Antibody-drug conjugate
MY215014AInactive Publication Date: 2026-08-21DAIICHI SANKYO CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2019000179
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2012-10-11
- Filing Date
- 2013-10-10
- Publication Date
- 2026-08-21
- Estimated Expiration
- Not applicable · inactive patent
Abstract
As an antitumor drug which is excellent in terms of antitumor effect and safety, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an antibody via a linker having a structure represented by the following formula: -L¹-L²-LP-NH- (CH₂ ) n¹-Lª-Lb-Lc- wherein the antibody is connected to the terminal of L¹, and the antitumor compound is connected to the terminal of Lc with the nitrogen atom of the amino group at position 1 as a connecting position. No Suitable Figure
Need to check novelty before this filing date? Find Prior Art